Chinese Antibody Society 2022 mAbTalk Symposium: Emerging Targets for Immuno-oncology

Fish is proud to support the Chinese Antibody Society2022 mAbTalk Symposium: Emerging Targets for Immuno-oncology, taking place on Saturday, May 21, live on Zoom.

With the development of biotechnology, immunotherapy has made significant progress and has become a novel cancer treatment. Though breakthroughs in immunotherapy have been made in recent years, including combination therapy and emergence of new targets, challenges in this innovative science prove to be an ongoing hurdle.

In view of the recent exciting development of cancer immunotherapy, the Chinese Antibody Society (CAS) and the CAS’s journal Antibody Therapeutics will host the Chinese Antibody Society mAbTalkTM Symposium: Emerging Targets for Immuno-oncology, where several established academic experts will discuss various novel cancer immunotherapies.

To learn more, click here.